Choong Ingrid 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Choong Ingrid
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-31+54,000→ 54,000 totalExercise: $0.86Exp: 2033-08-30→ Common Stock (54,000 underlying)
Footnotes (1)
- [F1]The option vests in equal installments over 48 months measured from August 31, 2023, subject to the Reporting Person's continuous service as of each such date.